... GE Healthcares new Vivid i ... cardiovascular ultrasound system to provide high-performance, full-featured ... Vivid i addresses one ... access to complete, real-time diagnostic information. ...
The Bio-Quant TROPONIN I test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac,troponin I (cTnI) in human serum specimens as an aid i...
This advanced digital monitor detects the appearance of an irregular heartbeat during measurement and gives a warning signal with your reading. An irregular heartbeat may cause or indicate cardiovasc...
... The Veris physiological monitor offers a comprehensive ... specifically designed for pediatric and neonate patients, ... to 3T. Veris is the first MR ... of pediatric and neonate patient monitoring. The ...
Medicine Products:(Date:12/7/2009)... Today the Centers for Disease Control and Prevention (CDC) ... the week was designed to highlight the importance of ... of taking additional steps to keep you and your ... of December, January and beyond. ,, "It,s easy to ... topic of both seasonal and swine flu," said Dr. ...
(Date:12/6/2009)... BROOK, Ill., Dec. 7 The University ... (AMC) members for their achievements in UHC,s Supply ... organizations are noted for modeling best practices in ... http://www.newscom.com/cgi-bin/prnh/20091207/CG21708 ) ,, The winners were determined ... that includes contract portfolio participation and use of ...
(Date:12/6/2009)... future treatments targeting growth factor, researchers say , , ... breast cancer cells from the main tumor to other ... factor known as TGFb, which may prove a promising ... British researchers say. , Previous studies have shown that ... and movement. In this new study, a team from ...
(Date:12/6/2009)... Dec. 6 Blood clotting, or coagulation, ... when a blood vessel is injured. Sometimes, however, ... an obvious injury or do not dissolve naturally, ... today at the 51st Annual Meeting of the ... of using the anticoagulants aspirin and heparin with ...
(Date:12/5/2009)... shown in a phase 1/2 clinical trial that ... of patients newly diagnosed with multiple myeloma, a cancer ... from Dana-Farber Cancer Institute. , Partial responses or better ... with the drug combination in the multi-center study, with ... in the phase 2 population, reports Paul G. Richardson, ...
Breaking Medicine News(10 mins):Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 2Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 3Health News:Recognized Top Performers in UHC Supply Chain 2Health News:Breast Cancer's Spread Now Better Understood 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2... Provide General Information about Potential Health ConcernsNEWTON, Mass., May ... in the reinvention of how people obtain legal services, ... general information about the potential health hazards of excessive ... consumer product used by an estimated 35 million Americans ...
... colleague Tom Daulton to provide strategic leadership as ... PRAIRIE, Wis., May 5 Devicor Medical Products, ... Executive Vice President, Corporate Development & Strategy. Salkin,s ... the Royal Bank of Scotland plc is highlighted ...
... BERLIN, May 5 Anatomist, Dr. Gunther von Hagens, ... set out three years ago to present the human ... his "HUMAN SAGA" project this week.(Photo: http://www.newscom.com/cgi-bin/prnh/20090505/CG11117 ... hoped to traverse the anatomical landscape left uncharted by ...
... According to a new study led by researchers at ... several factors that contribute to children missing immunization visits. ... presentation at 8:30 a.m. ET on Tuesday, May 5, ... here. , "We know that approximately 20 percent ...
... Will Host ,Day of Dialogue, Online Town Hall Meeting on ... America,s healthcare and long-term services need to undergo a ... seniors and people with disabilities, according to a report released ... report, which will be supported by a nationwide "Day of ...
... Health Care Management WASHINGTON, May 5 ... education organization, announced today that Christine G. Leyden, Senior ... Accreditation Officer for URAC has been recognized as a ... Point magazine. Ms. Leyden will be featured in ...
Other Medicine News:Health News:Sokolove Law Launches Denture Cream Consumer Hotline 2Health News:Jonathan Salkin Named Executive Vice President of Devicor Medical Products 2Health News:Dr. Gunther von Hagens 'HUMAN SAGA' Project Presents Sexuality and Reproduction in New Exhibit, The Cycle of Life. 2Health News:Why parents miss their children's immunization visits 2Health News:Why parents miss their children's immunization visits 3Health News:National Advisory Board Issues 'Declaration for Independence': A Call-to-Action in Healthcare for Seniors and People with Disabilities 2Health News:National Advisory Board Issues 'Declaration for Independence': A Call-to-Action in Healthcare for Seniors and People with Disabilities 3Health News:Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation 2Health News:Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation 3(Date:12/4/2009)... (Nasdaq: ONXX ) today announced that it will ... will discuss the data presentations surrounding carfilzomib in relapsed ... American Society of Hematology (ASH) Annual Meeting. ,, The ... on Monday, December 7, 2009. The live webcast ...
(Date:12/4/2009)... 4 Shared Imaging, LLC, an independent provider ... programs for hospitals and healthcare providers, is excited ... Accreditation for Ambulatory Health Care, a nationally-recognized, prestigious ... in patient care. Shared Imaging accreditation is system-wide ...
(Date:12/4/2009)... 4 Hospira, Inc. (NYSE: HSP ), ... today announced the launch of its next-generation 50 mL ... and solutions, and now offers a complete size range ... responsible VisIV product. The launch of the 50 mL ...
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Cynosure to Present at the Maxim Group Growth Conference 57944 1Cynosure to Present at the Maxim Group Growth Conference 57944 2New and Interesting PROSTVAC 28TM 29 Data Indicate Broad Therapeutic Use in Metastatic Prostate Cancer 14203 1New and Interesting PROSTVAC 28TM 29 Data Indicate Broad Therapeutic Use in Metastatic Prostate Cancer 14203 2New and Interesting PROSTVAC 28TM 29 Data Indicate Broad Therapeutic Use in Metastatic Prostate Cancer 14203 3Glaucoma Tied to Gene Variants in Blacks 57942 1Glaucoma Tied to Gene Variants in Blacks 57942 2